Symbiox Investment & Trading Co Board of Directors
Get the latest insights into the leadership at Symbiox Investment & Trading Co. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Samit Ray | Executive Director |
| Mrs. Sunita Show | Executive Director |
| Mr. Swapan Sardar | Independent Director |
| Mr. Bappa Mitra | Independent Director |
| Mrs. Mina Devi Agarwal | Independent Director |
| Mr. Nitesh Poddar | Independent Director |
Symbiox Investment & Trading Co Share price
SYMBIOX
2.89
0.09 (3.21%)Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
2.92
Today's Low
2.76
52 Week Low
2.33
52 Week High
6.02
The current prices are delayed, login to your account for live prices
LoginSymbiox Investment & Trading Co FAQs
The board at Symbiox Investment & Trading Co consists of experienced professionals, including Mr. Samit Ray , Mrs. Sunita Show , and others, overseeing the company’s strategic and corporate governance.
Directors at Symbiox Investment & Trading Co are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Samit Ray is the current chairman at Symbiox Investment & Trading Co.
Executive directors at Symbiox Investment & Trading Co are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Symbiox Investment & Trading Co adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Symbiox Investment & Trading Co, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.